|
gptkbp:instanceOf
|
Infectious disease
|
|
gptkbp:affects
|
gptkb:Humans
Animals
|
|
gptkbp:antibioticResistance
|
gptkb:Beta-lactam_antibiotics
gptkb:Methicillin
|
|
gptkbp:cause
|
Pneumonia
Urinary tract infections
Bloodstream infections
Skin and soft tissue infections
Surgical site infections
|
|
gptkbp:causedBy
|
gptkb:Methicillin-resistant_Staphylococcus_aureus
|
|
gptkbp:complication
|
gptkb:Osteomyelitis
Pneumonia
Sepsis
Endocarditis
|
|
gptkbp:diagnosedBy
|
gptkb:culture
PCR test
Antibiotic susceptibility testing
|
|
gptkbp:feature
|
gptkb:Nursing_homes
gptkb:community
Hospitals
|
|
gptkbp:firstDescribed
|
1961
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
MRSA infections
|
|
gptkbp:ICD-10_code
|
A49.02
|
|
gptkbp:mortalityRate
|
Varies by severity and setting
|
|
gptkbp:notableGroup
|
gptkb:CA-MRSA
gptkb:HA-MRSA
gptkb:LA-MRSA
|
|
gptkbp:prevalence
|
Worldwide
|
|
gptkbp:prevention
|
Hand hygiene
Cleaning surfaces
Contact precautions
|
|
gptkbp:publicHealthConcern
|
Yes
|
|
gptkbp:relatedTo
|
gptkb:Staphylococcus_aureus_infections
|
|
gptkbp:riskFactor
|
Surgery
Hospitalization
Close contact sports
Use of antibiotics
Weakened immune system
|
|
gptkbp:symptom
|
Fever
Pus or drainage
Red, swollen, painful skin
|
|
gptkbp:transmission
|
Contaminated surfaces
Direct contact
|
|
gptkbp:treatment
|
gptkb:Vancomycin
gptkb:Clindamycin
gptkb:Daptomycin
gptkb:Linezolid
|
|
gptkbp:bfsParent
|
gptkb:rifampin
gptkb:teicoplanin
|
|
gptkbp:bfsLayer
|
6
|